Investors Research Corp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-300
| Closed | -$36.8K | – | 888 |
|
|
2025
Q4 | $36.8K | Hold |
300
| – | – | 0.01% | 470 |
|
|
2025
Q3 | $33.3K | Sell |
300
-115
| -28% | -$13.1K | 0.01% | 485 |
|
|
2025
Q2 | $46K | Hold |
415
| – | – | 0.01% | 481 |
|
|
2025
Q1 | $46.5K | Sell |
415
-11,121
| -96% | -$1.15M | 0.01% | 474 |
|
|
2024
Q4 | $1.07M | Sell |
11,536
-2,216
| -16% | -$200K | 0.23% | 88 |
|
|
2024
Q3 | $1.15M | Hold |
13,752
| – | – | 0.25% | 82 |
|
|
2024
Q2 | $944K | Hold |
13,752
| – | – | 0.22% | 104 |
|
|
2024
Q1 | $1.01M | Sell |
13,752
-425
| -3% | -$32.7K | 0.24% | 107 |
|
|
2023
Q4 | $1.15M | Hold |
14,177
| – | – | 0.28% | 85 |
|
|
2023
Q3 | $1.06M | Sell |
14,177
-425
| -3% | -$32.7K | 0.28% | 86 |
|
|
2023
Q2 | $1.13M | Hold |
14,602
| – | – | 0.28% | 87 |
|
|
2023
Q1 | $1.21M | Hold |
14,602
| – | – | 0.31% | 74 |
|
|
2022
Q4 | $1.25M | Sell |
14,602
-192
| -1% | -$15.2K | 0.34% | 63 |
|
|
2022
Q3 | $913K | Buy |
14,794
+500
| +3% | +$31.5K | 0.28% | 92 |
|
|
2022
Q2 | $884K | Buy |
14,294
+1,228
| +9% | +$76K | 0.27% | 95 |
|
|
2022
Q1 | $777K | Buy |
13,066
+75
| +0.6% | +$4.79K | 0.22% | 128 |
|
|
2021
Q4 | $943K | Hold |
12,991
| – | – | 0.29% | 91 |
|
|
2021
Q3 | $907K | Hold |
12,991
| – | – | 0.31% | 95 |
|
|
2021
Q2 | $895K | Hold |
12,991
| – | – | 0.31% | 108 |
|
|
2021
Q1 | $840K | Sell |
12,991
-450
| -3% | -$29K | 0.32% | 110 |
|
|
2020
Q4 | $783K | Buy |
13,441
+8,435
| +168% | +$509K | 0.31% | 109 |
|
|
2020
Q3 | $316K | Hold |
5,006
| – | – | 0.15% | 197 |
|
|
2020
Q2 | $385K | Hold |
5,006
| – | – | 0.19% | 176 |
|
|
2020
Q1 | $374K | Hold |
5,006
| – | – | 0.23% | 157 |
|
|
2019
Q4 | $325K | Hold |
5,006
| – | – | 0.15% | 211 |
|
|
2019
Q3 | $317K | Buy |
5,006
+94
| +2% | +$6.14K | 0.16% | 194 |
|
|
2019
Q2 | $332K | Hold |
4,912
| – | – | 0.17% | 179 |
|
|
2019
Q1 | $319K | Hold |
4,912
| – | – | 0.17% | 182 |
|
|
2018
Q4 | $307K | Hold |
4,912
| – | – | 0.21% | 175 |
|
|
2018
Q3 | $379K | Buy |
4,912
+117
| +2% | +$8.84K | 0.22% | 176 |
|
|
2018
Q2 | $340K | Buy |
4,795
+45
| +0.9% | +$3.18K | 0.2% | 192 |
|
|
2018
Q1 | $358K | Hold |
4,750
| – | – | 0.22% | 185 |
|
|
2017
Q4 | $340K | Buy |
+4,750
| New | +$361K | 0.21% | 187 |
|
Other funds holding GILD
Investors Research Corp's GILD Position: Q1 2026 in Review
Investors Research Corp sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 300 shares — an estimated $36.8K sold.
Investors Research Corp first reported a position in GILD in Q4 2017 and held it in 33 quarters. The position peaked at $1.25M in Q4 2022. 2,331 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Investors Research Corp reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Investors Research Corp sold 300 Gilead Sciences shares in Q1 2026, an estimated $36.8K.
- Investors Research Corp first reported a position in Gilead Sciences in Q4 2017 and held it in 33 quarters.
- Investors Research Corp's Gilead Sciences position peaked at $1.25M in Q4 2022.
- 2,331 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Investors Research Corp's 13F filing for Q1 2026, filed 3 Apr 2026.